Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile.

Source:http://linkedlifedata.com/resource/pubmed/id/12231090

Am. J. Cardiol. 2002 Sep 15 90 6 628-30

Download in:

View as

Triples

General Info

PMID
12231090